Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Conference Flash: Radiation Therapy after Lumpectomy Can be Shortened
Tracy Hampton, PhD, MDLinx Oncology
Medicare Final Rule for 2010: E-Prescribing and Compendia
Roberta Buell, MBA, Sausalito Healthcare Partners
Technology Advances: HPV Vaccine Therapeutic for Vulvar Premalignancy
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Myeloproliferative Dz



Latest (2) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia
Leukemia Research, 12/30/08
Sponsor
Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes
Leukemia Research, 12/30/08
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
Leukemia Research, 12/30/08
Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
Leukemia Research, 12/23/08
Are new agents really making a difference in MDS
Best Practice & Research: Clinical Haematology, 12/18/08
Tumor suppressor gene inactivation in myeloid malignancies
Best Practice & Research: Clinical Haematology, 12/18/08
Effect of Magnetic Resonance Myelography on the Target Volume in Craniospinal Irradiation in Children
Clinical Oncology, 12/18/08
Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo
Blood, 12/17/08    Evidence Based Medicine
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders
Haematologica, 12/17/08    Free full text
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
Haematologica, 12/17/08    Free full text
New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression
Leukemia and Lymphoma, 12/17/08
Enhanced histone deacetylase enzyme activity in primary myelofibrosis
Leukemia and Lymphoma, 12/16/08
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy
Leukemia and Lymphoma, 12/16/08
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: Sequential improvement of response and achievement of complete response are associated with longer survival
Journal of Clinical Oncology, 12/15/08
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
Journal of Clinical Oncology, 12/15/08    Evidence Based Medicine
Abnormal cytoplasmic dyslocalisation and/or reduction of nucleophosmin protein level rarely occurs in myelodysplastic syndromes
Leukemia and Lymphoma, 12/10/08
Serum transforming growth factor-beta1 is related to the degree of immunoparesis in patients with multiple myeloma
Medical Oncology, 12/08/08
Dexamethasone reverses glucocorticoid receptor rna depression in multi-drug resistant (MDR) myeloma cell lines
Medical Oncology, 12/08/08
Idiotype-specific T cells in multiple myeloma:Targets for an immunotherapeutic intervention
Medical Oncology, 12/08/08
Multiple myeloma, high-dose treatment and autologous stem cell transplantation-current status
Medical Oncology, 12/08/08

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
189 Available Pages
First    Prev    17      18      19      20      21      22      23      24      25      26      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.